Ram C Shankaraiah (Ram Shankaraiah)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2019
Publications (10 Years): 3

Top Topics

Functional Connectivity

Brain Metastases

Cerebral Ischemia

Top Venues

NPJ breast cancer

Science translational medicine

Università degli Studi di Ferrara

Università degli Studi di Ferrara (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Università degli Studi di Ferrara Feb 05 2019

Italy

Post doctoral research fellow :: Morphology, Surgery and Experimental medicine

Massachusetts General Hospital Department of Radiation Oncology Sep 01 2013 - Apr 01 2015

United States

Research Fellow :: Steele laboratory

Education History

Università degli Studi di Ferrara Nov 01 2015 - Feb 04 2019

Italy

PHD :: Medical Oncology

Vrije Universiteit Amsterdam Sep 02 2012 - Sep 02 2014

Netherlands

MSC :: Medical Oncology

Publications

Ram C Shankaraiah, Laura Gramantieri, Francesca Fornari, Silvia Sabbioni, Elisa Callegari, Massimo Negrini
Animal Models of Hepatocellular Carcinoma Prevention. Cancers 11 (11) (2019)
Vasileios Askoxylakis, Gino B Ferraro, Mark Badeaux, David P Kodack, Isabelle Kirst, Ram C Shankaraiah, Christina S F Wong, Dan G Duda, Dai Fukumura, Rakesh K Jain
Dual endothelin receptor inhibition enhances T-DM1 efficacy in brain metastases from HER2-positive breast cancer. NPJ breast cancer 5 (2019)
David P Kodack, Vasileios Askoxylakis, Gino B Ferraro, Qing Sheng, Mark Badeaux, Shom Goel, Xiaolong Qi, Ram C Shankaraiah, Z Alexander Cao, Rakesh R Ramjiawan, Divya Bezwada, Bhushankumar Patel, Youngchul Song, Carlotta Costa, Kamila Naxerova, Christina S F Wong, Jonas Kloepper, Rita Das, Angela Tam, Jantima Tanboon, Dan G Duda, C Ryan Miller, Marni B Siegel, Carey K Anders, Melinda E Sanders, M Valeria Estrada, Robert Schlegel, Carlos L Arteaga, Elena Brachtel, Alan Huang, Dai Fukumura, Jeffrey A Engelman, Rakesh K Jain
The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation. Science translational medicine 9 (391) (2018)